# MuscleCare™ Pain Relief Therapy vs. Voltaren® in the Relief of Trapezius Trigger Point Musculoskeletal Pain.

> **NCT03939884** · PHASE4 · COMPLETED · sponsor: **University of Toronto** · enrollment: 120 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** MuscleCare Topical Product
- **DRUG:** Voltaren Topical
- **DRUG:** Nivea, Topical Cream

## Key facts

- **NCT ID:** NCT03939884
- **Lead sponsor:** University of Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-28
- **Primary completion:** 2018-02-25
- **Final completion:** 2018-02-25
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03939884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03939884, "MuscleCare™ Pain Relief Therapy vs. Voltaren® in the Relief of Trapezius Trigger Point Musculoskeletal Pain.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03939884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*